Literature DB >> 17482

Simultaneous measurement of phenobarbital, phenytoin, primidone, ethosuximide, and carbamazepine in serum by high-pressure liquid chromatography.

P M Kabra, B E Stafford, L J Marton.   

Abstract

We present a method for simultaneously determining five anticonvulsants [phenobarbital, phenytoin (diphenylhydantoin), primidone, ethosuximide, and carbamazepine] in as little as 25 microliters of serum. The proteins are precipitated with an acetonitrile solution containing hexobarbital as an internal standard. The anticonvulsants are eluted from a reversed-phase column with a mobile phase consisting of an acetonitrile/phosphate buffer (19/81 by vol) at a flow rate of 3.0 ml/min. The eluted drugs are detected by their absorption at 195 nm, and quantities estimated from their peak heights. Each analysis requires about 14 min. at an optimum column temperature of 50 degrees C. The lower unit of detection for all of these drugs is less than 10 ng. Sensitivities, for serum samples, of 1.0 mg/liter for all the drugs analyzed are attained routinely. Analytical recoveries for the five drugs varied from 97 - 107%, with good day-to-day precision (CV between 3.9 and 5.9%). Of more than 30 drugs tested for possible interference, only ethotoin interferes with the analysis of phenobarbital.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17482

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy.

Authors:  H Gough; A Bissesar; T Goggin; D Higgins; M Baker; M Crowley; N Callaghan
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

3.  A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.

Authors:  N Callaghan; R A Kenny; B O'Neill; M Crowley; T Goggin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

4.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

Review 5.  Therapeutic drug monitoring: a comprehensive and critical review of analytical methods for anticonvulsive drugs.

Authors:  A H Kumps
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

6.  Performance characteristics of bioassay, radioenzymatic assay, homogeneous enzyme immunoassay, and high-performance liquid chromatographic determination of serum gentamicin.

Authors:  C J Delaney; K E Opheim; A L Smith; J J Plorde
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  A comparison of plasma and saliva levels of carbamazepine and phenytoin as monotherapy.

Authors:  N Callaghan; T Goggin
Journal:  Ir J Med Sci       Date:  1984-05       Impact factor: 1.568

8.  High-performance liquid chromatographic assay of chloramphenicol in serum.

Authors:  J R Koup; B Brodsky; A Lau; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

9.  Fetal phenytoin exposure, hypoplastic nails, and jitteriness.

Authors:  S W D'Souza; I G Robertson; D Donnai; G Mawer
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.